Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Tourmaline Bio Inc.

    NASDAQ: TRML · Real-Time Price · USD
    18.35
    -0.62 (-3.27%)
    At close: Jun 17, 2025, 2:45 PM

    Tourmaline Bio Statistics

    Share Statistics

    Tourmaline Bio has 25.69M shares outstanding. The number of shares has increased by 0.15% in one year.

    Shares Outstanding

    n/a
    		 25.69M

    Shares Change (YoY)

    n/a
    		 0.15%

    Shares Change (QoQ)

    n/a
    		 0.17%

    Owned by Institutions (%)

    n/a
    		 85.49%

    Shares Floating

    n/a
    		 16.37M

    Failed to Deliver (FTD) Shares

    n/a
    		 12,097

    FTD / Avg. Volume

    n/a
    		 3.4%

    Short Selling Information

    The latest short interest is 3.08M, so 12.01% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.08M

    Short % of Shares Out

    n/a
    		 12.01%

    Short % of Float

    n/a
    		 13.44%

    Short Ratio (days to cover)

    n/a
    		 8.25

    Valuation Ratios

    The PE ratio is -7.02 and the forward PE ratio is -4.75. Tourmaline Bio's PEG ratio is 0.1.

    PE Ratio

    n/a
    		 -7.02

    Forward PE

    n/a
    		 -4.75

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 6.4

    PB Ratio

    n/a
    		 1.71

    P/FCF Ratio

    n/a
    		 -6.65

    PEG Ratio

    n/a
    		 0.1
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Tourmaline Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 30.18, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 30.18

    Quick Ratio

    n/a
    		 30.18

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-989,324.32

    Employee Count

    n/a
    		 74

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 26.06% in the last 52 weeks. The beta is 2.06, so Tourmaline Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.06

    52-Week Price Change

    n/a
    		 26.06%

    50-Day Moving Average

    n/a
    		 16.24

    200-Day Moving Average

    n/a
    		 19.42

    Relative Strength Index (RSI)

    n/a
    		 61.55

    Average Volume (20 Days)

    n/a
    		 355,744

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -89.73M

    Net Income

    n/a
    		 -73.21M

    EBITDA

    n/a
    		 -89.73M

    EBIT

    n/a
    		 -73.21M

    Earnings Per Share (EPS)

    n/a
    		 -2.89
    Full Income Statement

    Balance Sheet

    The company has 30.51M in cash and 244K in debt, giving a net cash position of 30.26M.

    Cash & Cash Equivalents

    n/a
    		 30.51M

    Total Debt

    n/a
    		 244K

    Net Cash

    n/a
    		 30.26M

    Retained Earnings

    n/a
    		 -135.26M

    Total Assets

    n/a
    		 287.5M

    Working Capital

    n/a
    		 250.52M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -77.26M and capital expenditures -9K, giving a free cash flow of -77.27M.

    Operating Cash Flow

    n/a
    		 -77.26M

    Capital Expenditures

    n/a
    		 -9K

    Free Cash Flow

    n/a
    		 -77.27M

    FCF Per Share

    n/a
    		 -3.05
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    TRML does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TRML is $50, which is 163.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $50

    Price Target Difference

    n/a
    		 163.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 20, 2023. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Oct 20, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 32.47

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist